1. A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes
    Thomas Jax et al, 2017, Cardiovascular Diabetology CrossRef
  2. The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus: A Retrospective and Observational Study
    Natsumi Matsuoka-Uchiyama et al, 2022, Journal of Diabetes Research CrossRef
  3. The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)
    null null et al, 2017, Cardiovascular Diabetology CrossRef
  4. Effects of dipeptidyl peptidase 4 inhibition on the endothelial control of the vascular tone
    Joao Carlos Ribeiro-Silva et al, 2023, American Journal of Physiology-Cell Physiology CrossRef
  5. Exploring the modulatory effects of sotagliflozin on dyslipidemia in mice: The role of glucagon, fibroblast growth factor 21 and glucagon‐like peptide 1
    Nitin J. Deshmukh et al, 2024, Clinical and Experimental Pharmacology and Physiology CrossRef
  6. Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging
    Fen Cao et al, 2021, Frontiers in Endocrinology CrossRef
  7. Small HDL subclasses become cholesterol-poor during postprandial period after a fat diet intake in subjects with high triglyceridemia increases
    Armando Quintanilla-Cantú et al, 2017, Clinica Chimica Acta CrossRef
  8. Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
    Michał Wiciński et al, 2020, International Journal of Molecular Sciences CrossRef
  9. Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?
    Paul D. Rosenblit, 2016, Cardiovascular Diabetology CrossRef
  10. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review
    Genovefa D. Kolovou et al, 2019, Current Vascular Pharmacology CrossRef